Login / Signup

Effect of highly effective modulator therapy on quality of life in adults with cystic fibrosis.

Emily DiMangoDaniel B SpielmanJonathan OverdevestClaire KeatingSarah Fracasso FrancisDavid DanskyDavid A Gudis
Published in: International forum of allergy & rhinology (2020)
CF patients taking elexacaftor/tezacaftor/ivacaftor experience a significant improvement in both sinonasal and health-related quality of life.
Keyphrases
  • cystic fibrosis
  • end stage renal disease
  • pseudomonas aeruginosa
  • ejection fraction
  • chronic kidney disease
  • lung function
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • air pollution